Posts by: Joana Carvalho, PhD

Joana Carvalho, PhD

Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that made up the lining of blood vessels — found in the umbilical cord of newborns.

June 30, 2020June 30, 2020

Breztri Aerosphere Leads to Lower COPD Exacerbation Rate Compared With Dual Therapies, Trial Shows

News

Breztri Aerosphere, AstraZeneca’s triple combination therapy for chronic obstructive pulmonary disease (COPD), significantly reduces the frequency of moderate or severe exacerbations, compared to dual combination therapies, in patients with ... Read more

June 4, 2020June 4, 2020

Stem Cell Therapy Benefits Patients with Severe Inflammation, Trial Data Show

News

Remestemcel-L, Mesoblast’s lead candidate stem cell therapy for inflammatory diseases, improves lung function and exercise capacity in people with chronic obstructive pulmonary disease (COPD) and a high degree of inflammation, ... Read more

May 21, 2020May 21, 2020

COPD Seen to Raise Risk of Lung Cancer in Non-smokers

News

Chronic obstructive pulmonary disease (COPD) is linked to a higher risk of lung cancer in people who never smoked. In fact, their risk is equivalent to current or former ... Read more

October 29, 2019October 29, 2019

Duaklir Now Available to COPD Patients in US, Circassia Announces

News

Duaklir (aclidinium bromide and formoterol fumarate), a long-term maintenance treatment for chronic obstructive pulmonary disease (COPD), is available to patients living in the U.S., Circassia Pharmaceuticals announced. According to ... Read more

October 25, 2019October 25, 2019

Tudorza Reduces COPD Flare-ups Without Increasing Risk of Cardiovascular Complications or Death, Phase 4 Trial Shows

News

Tudorza (aclidinium bromide) reduces flare-ups in patients with moderate to severe chronic obstructive pulmonary disease (COPD) without increasing the risk of cardiovascular complications such as heart attack and stroke, ... Read more

September 24, 2019September 24, 2019

Vaping Triggers Cellular Responses Similar to Cigarette Smoking, Potentially Increasing Risk of Emphysema

News

The use of electronic cigarettes, more commonly known as vaping, triggers cellular responses in the lungs similar to those elicited by smoking tobacco cigarettes, which may place e-cigarette users ... Read more

August 27, 2019August 27, 2019

COPD Patients With Acute Exacerbations Should Receive Noninvasive Ventilation Regardless of Certain Characteristics, Study Suggests

News

Patients with chronic obstructive pulmonary disease (COPD) who are experiencing severe exacerbations should receive noninvasive ventilation, regardless of factors such as older age, low body mass index (BMI), left ... Read more

August 20, 2019August 20, 2019

Findings of 3 Studies of Nerve Ablation Therapy in COPD Patients to Appear in Science Journals, Nuvaira Says

News

Nuvaira, a medical device company, announced the upcoming publication of several scientific studies detailing the findings of clinical trials that assessed the safety and effectiveness of its Targeted Lung Denervation ... Read more

August 13, 2019August 13, 2019

Spiration Valve System Helps People with Severe Emphysema Breathe More Easily, Study Finds

News

Olympus‘ Spiration Valve System (SVS), a device that can be inserted into a patient’s airways to redirect air from diseased regions of the lungs and toward its healthier parts, ... Read more

July 2, 2019July 2, 2019

COPD Patients at Greater Risk of Fractures and Osteoporosis Than Those with Other Diseases, UK Study Finds

News

Patients with chronic obstructive pulmonary disease (COPD) are more susceptible to bone fractures and osteoporosis than those of the same age and sex without this disease, a study reports. The ... Read more

Pin It on Pinterest